117 related articles for article (PubMed ID: 21679284)
1. Acromegaly: presentation, morbidity and treatment outcomes at a single centre.
Anagnostis P; Efstathiadou ZA; Polyzos SA; Adamidou F; Slavakis A; Sapranidis M; Litsas ID; Katergari S; Selalmatzidou D; Kita M
Int J Clin Pract; 2011 Aug; 65(8):896-902. PubMed ID: 21679284
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcomes and mortality of 94 patients with acromegaly.
Trepp R; Stettler C; Zwahlen M; Seiler R; Diem P; Christ ER
Acta Neurochir (Wien); 2005 Mar; 147(3):243-51; discussion 250-1. PubMed ID: 15627919
[TBL] [Abstract][Full Text] [Related]
3. Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease.
Mercado M; Espinosa de los Monteros AL; Sosa E; Cheng S; Mendoza V; Hernández I; Sandoval C; Guinto G; Molina M
Horm Res; 2004; 62(6):293-9. PubMed ID: 15542931
[TBL] [Abstract][Full Text] [Related]
4. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas.
Minniti G; Jaffrain-Rea ML; Osti M; Esposito V; Santoro A; Solda F; Gargiulo P; Tamburrano G; Enrici RM
Clin Endocrinol (Oxf); 2005 Feb; 62(2):210-6. PubMed ID: 15670198
[TBL] [Abstract][Full Text] [Related]
5. Gamma knife radiosurgery for acromegaly--long-term experience.
Jezková J; Marek J; Hána V; Krsek M; Weiss V; Vladyka V; Lisák R; Vymazal J; Pecen L
Clin Endocrinol (Oxf); 2006 May; 64(5):588-95. PubMed ID: 16649981
[TBL] [Abstract][Full Text] [Related]
6. [The OASIS study: therapeutic management of acromegaly in standard clinical practice. Assessment of the efficacy of various treatment strategies].
Luque-Ramírez M; Carreño A; Alvarez Escolá C; del Pozo Picó C; Varela da Costa C; Fajardo Montañana C; Gilabert M; Webb S;
Endocrinol Nutr; 2011 Nov; 58(9):478-86. PubMed ID: 22032858
[TBL] [Abstract][Full Text] [Related]
7. A follow-up of 130 patients with acromegaly in a single centre.
Bolanowski M; Zatonska K; Kaluzny M; Zielinski G; Bednarek-Tupikowska G; Bohdanowicz-Pawlak A; Daroszewski J; Szymczak J; Podgorski JK
Neuro Endocrinol Lett; 2006 Dec; 27(6):828-32. PubMed ID: 17187024
[TBL] [Abstract][Full Text] [Related]
8. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
9. Gamma-knife surgery is effective in normalising plasma insulin-like growth factor I in patients with acromegaly.
Gutt B; Wowra B; Alexandrov R; Uhl E; Schaaf L; Stalla GK; Schopohl J
Exp Clin Endocrinol Diabetes; 2005 Apr; 113(4):219-24. PubMed ID: 15891958
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.
Jallad RS; Musolino NR; Salgado LR; Bronstein MD
Clin Endocrinol (Oxf); 2005 Aug; 63(2):168-75. PubMed ID: 16060910
[TBL] [Abstract][Full Text] [Related]
11. Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients.
Resmini E; Barreca A; Ferone D; Giusti M; Sidoti M; Minuto F
Clin Endocrinol (Oxf); 2005 Sep; 63(3):294-7. PubMed ID: 16117816
[TBL] [Abstract][Full Text] [Related]
12. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
Laczi F; Magony S; Julesz J
Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
[TBL] [Abstract][Full Text] [Related]
13. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
Plöckinger U; Quabbe HJ
Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women.
Caron P; Broussaud S; Bertherat J; Borson-Chazot F; Brue T; Cortet-Rudelli C; Chanson P
J Clin Endocrinol Metab; 2010 Oct; 95(10):4680-7. PubMed ID: 20660047
[TBL] [Abstract][Full Text] [Related]
15. [Transsphenoidal resection of pituitary adenomas: long-term results from the Leiden University Medical Center].
Biermasz NR; Dekkers OM; Voormolen J; de Keizer RJ; Neelis KJ; Wiggers-de Bruïne FT; Smit JW; Arias AM; Romijn JA
Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2565-70. PubMed ID: 19174939
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy or surgery as primary treatment for acromegaly?
Ferone D; Colao A; van der Lely AJ; Lamberts SW
Drugs Aging; 2000 Aug; 17(2):81-92. PubMed ID: 10984197
[TBL] [Abstract][Full Text] [Related]
17. A long-term follow-up study of eighteen patients with thyrotrophin-secreting pituitary adenomas.
van Varsseveld NC; Bisschop PH; Biermasz NR; Pereira AM; Fliers E; Drent ML
Clin Endocrinol (Oxf); 2014 Mar; 80(3):395-402. PubMed ID: 23848527
[TBL] [Abstract][Full Text] [Related]
18. Emerging trends in the diagnosis and treatment of acromegaly in Canada.
Vallette S; Ezzat S; Chik C; Ur E; Imran SA; Van Uum S; Rivera J; Caspar-Bell G; Serri O
Clin Endocrinol (Oxf); 2013 Jul; 79(1):79-85. PubMed ID: 23190441
[TBL] [Abstract][Full Text] [Related]
19. Biochemical Control in Acromegaly With Multimodality Therapies: Outcomes From a Pituitary Center and Changes Over Time.
Ghajar A; Jones PS; Guarda FJ; Faje A; Tritos NA; Miller KK; Swearingen B; Nachtigall LB
J Clin Endocrinol Metab; 2020 Mar; 105(3):e532-43. PubMed ID: 31701145
[TBL] [Abstract][Full Text] [Related]
20. Long-term treatment outcomes of acromegaly patients presenting biochemically-uncontrolled at a tertiary pituitary center.
Carmichael JD; Broder MS; Cherepanov D; Chang E; Mamelak A; Said Q; Neary MP; Bonert V
BMC Endocr Disord; 2017 Aug; 17(1):49. PubMed ID: 28778166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
